Snowball logo
logo
BITR_logo

Biotron Limited

BITRF • PINK
$0.0015$0.00  (0%)
Estimate
Beta
-0.64
Growth
Revenue, YoY
-71.02%
Net income, YoY
-185.63%
FCF, YoY
-286.47%
About the company
Ticker
BITRF
ISIN
Country
Australia
Sector (GICS)
Healthcare
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 that is in Phase 2 clinical trial for the treatment of HIV-1, as well as to treat hepatitis C virus infections; and BIT-HBV001 to treat hepatitis B virus and hepatitis delta virus. It also develops preclinical drugs for viral diseases, such as dengue, zika, and influenza virus. The company was incorporated in 1999 and is based in Sydney, Australia.

Frequently asked questions

What sector does Biotron Limited (BITRF) operate in?

Biotron Limited belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Biotron Limited (BITRF) current stock price?

As of the latest data, Biotron Limited stock price is $0.00, with a previous close of $0.00.

What is Biotron Limited (BITRF) current market capitalization?

Biotron Limited market cap is approximately 4.18 million.

What is Biotron Limited (BITRF) EBITDA?

Biotron Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.03 million.

Does Biotron Limited (BITRF) pay dividends?

No. Biotron Limited does not pay a dividend.

What is Biotron Limited (BITRF) beta (volatility) score?

Biotron Limited has a beta of -0.640, indicating lower volatility than the overall market.